Fundraising FoxAdgero Biopharmaceuticals Holdings
New York, US · Founded 2015 · Delaware corporation
Find your way into Adgero Biopharmaceuticals Holdings
Sign up to see every warm intro you have to Adgero Biopharmaceuticals Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Adgero Biopharmaceuticals Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JB
John BrancaccioExecutive
Board
DH
David HochmanBoard director
Reported raises · per SEC filings
Form D private placements$3.5M disclosed across 3 rounds · 2015–2016
▶$459KraisedSep 2016 · 21 investors · BiotechnologyRule 506(b)
▶$459KraisedSep 2016 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steve RychnovskyExecutive Officer
- Tim McInerneyDirector
- David P. HochmanDirector
- Frank PilkiewiczExecutive Officer, Director
- Allen BloomDirector
- Roman Perez-SolerDirector
- Offering amount
- $2M
- Amount sold
- $459K
- Sales commissions
- $260K
- Placement agents
- Aegis Capital Corp.
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$3MraisedApr 2016 · 39 investors · BiotechnologyRule 506(b)
▶$3MraisedApr 2016 · 39 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steve RychnovskyExecutive Officer
- Roman Perez-SolerDirector
- David P. HochmanDirector
- Frank PilkiewiczExecutive Officer, Director
- Allen BloomDirector
- Tim McInerneyDirector
- Offering amount
- $15M
- Amount sold
- $3M
- Sales commissions
- $1.9M
- Proceeds to insiders
- $222K
- Placement agents
- Aegis Capital Corp.
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$39.8KraisedNov 2015 · 9 investors · InvestingRule 506(b)
▶$39.8KraisedNov 2015 · 9 investors · Investing
Rule 506(b)Officers, directors & promoters on the filing
- John BrancaccioExecutive Officer
- David HochmanExecutive Officer, Director
- Offering amount
- $50K
- Amount sold
- $39.8K
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Adgero Biopharmaceuticals Holdings raised?
- Adgero Biopharmaceuticals Holdings has disclosed $3.5M raised across 3 rounds.
- Where is Adgero Biopharmaceuticals Holdings headquartered?
- Adgero Biopharmaceuticals Holdings is headquartered in New York, US.